Clinical Practice Use of Liquid Biopsy to Identify RAS/BRAF Mutations in Patients with Metastatic Colorectal Cancer (mCRC): A Single Institution Experience

Tumor heterogeneity represents a possible cause of error in detecting predictive genetic alterations on tumor tissue and can be overcome by testing alterations in circulating tumor DNA (ctDNA) using liquid biopsy. We assessed 72 consecutive patients with a diagnosis of metastatic colorectal cancer (...

Descripción completa

Detalles Bibliográficos
Autores principales: Vitiello, Pietro Paolo, De Falco, Vincenzo, Giunta, Emilio Francesco, Ciardiello, Davide, Cardone, Claudia, Vitale, Pasquale, Zanaletti, Nicoletta, Borrelli, Carola, Poliero, Luca, Terminiello, Marinella, Arrichiello, Gianluca, Caputo, Vincenza, Famiglietti, Vincenzo, Mattera Iacono, Valentina, Marrone, Francesca, Di Liello, Alessandra, Martini, Giulia, Napolitano, Stefania, Caraglia, Michele, Lombardi, Angela, Franco, Renato, De Vita, Ferdinando, Morgillo, Floriana, Troiani, Teresa, Ciardiello, Fortunato, Martinelli, Erika
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6827157/
https://www.ncbi.nlm.nih.gov/pubmed/31597339
http://dx.doi.org/10.3390/cancers11101504

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6827157/
https://www.ncbi.nlm.nih.gov/pubmed/31597339
http://dx.doi.org/10.3390/cancers11101504

Ejemplares similares